Detalles de la búsqueda
1.
Transitioning to home and beyond following stroke: a prospective cohort study of outcomes and needs.
BMC Health Serv Res
; 24(1): 449, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38600523
2.
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
Lancet
; 400(10361): 1405-1416, 2022 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36130612
3.
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
Lancet
; 399(10333): 1401-1410, 2022 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35390320
4.
Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years.
Nephrol Dial Transplant
; 37(2): 304-310, 2022 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34109413
5.
Effectiveness of interventions to support the transition home after acute stroke: a systematic review and meta-analysis.
BMC Health Serv Res
; 22(1): 1095, 2022 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031608
6.
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.
Lancet
; 395(10234): 1444-1451, 2020 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32234534
7.
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry.
Eur Heart J
; 40(42): 3474-3482, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30907413
8.
Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial.
Eur Heart J
; 40(9): 743-751, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30608521
9.
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
Lancet
; 391(10137): 2346-2355, 2018 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29803589
10.
Experimental evidence for heterospecific alarm signal recognition via associative learning in wild capuchin monkeys.
Anim Cogn
; 22(5): 687-695, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31069567
11.
Efficacy and Safety of Renal Denervation for Patients with Uncontrolled Hypertension in Taiwan: 3-Year Results From the Global SYMPLICITY Registry-Taiwan (GSR-Taiwan).
Acta Cardiol Sin
; 35(6): 618-626, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879514
12.
Data at 36 months for the Symplicity SPYRAL HTN-ON MED pilot - Authors' reply.
Lancet
; 400(10351): 492, 2022 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35964608
13.
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
Lancet
; 390(10108): 2160-2170, 2017 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28859944
14.
The East-West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts.
Am Heart J
; 206: 61-71, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30342296
15.
Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.
Eur Heart J
; 38(2): 93-100, 2017 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28158510
16.
Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohorts.
Am Heart J
; 182: 103-110, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27914489
17.
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.
Eur Heart J
; 36(4): 219-27, 2015 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25400162
18.
Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy.
Eur Heart J
; 35(23): 1533-40, 2014 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24603308
19.
Twenty-Four-Hour Ambulatory Blood Pressure Reduction Patterns After Renal Denervation in the SPYRAL HTN-OFF MED Trial.
Circulation
; 138(15): 1602-1604, 2018 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30354518
20.
Comparative effectiveness of upstream glycoprotein IIb/IIIa inhibitors in patients with moderate- and high-risk acute coronary syndromes: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy.
Am Heart J
; 167(1): 43-50, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24332141